New ovarian cancer screening test offers hope for early detectionA new test to screen for ovarian cancer appears to detect the disease in early stages, and if confirmed in clinical trials, the test could become a routine screening for womenBahar Gholipour...
Results provide initial guidance toward development of interventions to promote adaptive responses after receipt of an abnormal cancer screening test result.doi:10.1300/J077v25n04_01Patricia Y. Ryan PhD, RN, AOCNKristi D. Graves PhDEdward J. Pavlik PhD...
Screening for Ovarian Cancer: An Evidence Review for the US Preventive Services Task Force: Evidence Synthesis No. 157. Rockville, MD: Agency for Healthcare Research and Quality; 2018. AHRQ publication 17-05231-EF-1. 4. Henderson JT, Webber EM, Sawaya GF. Screening for ovarian cancer: an ...
To the Editor.—The study by Helzlsouer et al1concludes that CA-125 levels are not sensitive enough to screen for ovarian cancer. We believe that this test is an effective screening tool if used correctly.In their study, Helzlsouer et al1used a single CA-125 determination from 1974 as ...
Dr Maurie Markman warns against false claims by companies that market ovarian cancer screening tests and makes the case for more oversight of these tests by the FDA.
doi:10.1007/BF01236380Maurie MarkmanSpringer-VerlagJournal of Cancer Research and Clinical Oncology↵ Markman M. Screening for ovarian cancer: Is it appropriate? J Cancer Res Clin Oncol 1994 ; 120 : 257 –258.
The only available screening tests for ovarian cancer fail to catch early signs of the disease and often result in unnecessary surgery, said researchers at the University of Alabama at Birmingham (UAB) Comprehensive Cancer Center. Ad The new study looked at a screening regimen that combines ultraso...
Pictures show the symptoms, tests, and treatments for ovarian cancer, as well as what factors raise your risk for the disease.
A more than 30-year study into the long-term impact on mortality rates of screening for ovarian cancer has found that the cancer can be detected early and before women develop symptoms, but it does not translate to saving lives.
They used 35 U/mL as the level predictive of probable ovarian cancer. Two problems in experimental design critically weaken their conclusions.First, screening with CA-125 or any other test is not done once every 14 years. With only a single CA-125 determination measured as many as 14 years...